P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphism.

Abstract:

:The aim of the current study was to compare the pharmacokinetics of phenobarbital (PB) in extensive metabolizers (EMs) and poor metabolizers (PMs) of S-mephenytoin. Ten healthy volunteers (5 EMs and 5 PMs) were given 30 mg PB daily for 14 days. PB and p-hydroxyphenobarbital (p-OHPB) in serum and urine were measured by high-performance liquid chromatography (HPLC). Urinary excretion (12.5% versus 7.7%) and formation clearance (29.8 versus 21.1 mL/h) of p-OHPB, one of the main metabolites of PB, were significantly lower (p < .05) in PMs than in EMs. However, area under the serum concentration-time curve (153.3 in the EMs versus 122.9 microg x h/mL in the PMs), total (210.8 versus 254.9 mL/h) and renal clearance (53.1 versus 66.1 mL/h) of PB were identical between the two groups. To compare the inducibility of CYP2C19, mephenytoin was also given prior to and on the last day of PB treatment. The urinary level of 4'-hydroxymephenytoin was analyzed by a validated gas chromatograpy/mass spectrometry (GC/MS) method. The mephenytoin hydroxylation index did not change in either EMs (1.42 versus 1.42) or PMs (341.4 versus 403.5), showing that CYP2C19 was not induced by treatment with PB. These results indicated that the p-hydroxylation pathway of PB co-segregates with the CYP2C19 metabolic polymorphism. However, the overall disposition kinetics of PB were not different between EMs and PMs, and therefore polymorphic CYP2C19 seems have no major clinical implications.

journal_name

Ther Drug Monit

authors

Hadama A,Ieiri I,Morita T,Kimura M,Urae A,Irie S,Kaneda T,Mamiya K,Tashiro N,Higuchi S,Otsubo K

doi

10.1097/00007691-200104000-00004

subject

Has Abstract

pub_date

2001-04-01 00:00:00

pages

115-8

issue

2

eissn

0163-4356

issn

1536-3694

journal_volume

23

pub_type

临床试验,杂志文章
  • Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring.

    abstract::Trough levels (TL) of cyclosporine (CS) measured in serum by the polyclonal radioimmunoassay (SR) are useful for dissecting the etiology of clinical events, but they are a poor guide to dosage adjustments. In renal transplant patients immunosuppressed by low doses of prednisone and CS given orally, once-a-day TL (24-h...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:

    authors: Grevel J,Welsh MS,Kahan BD

    更新日期:1989-01-01 00:00:00

  • Binding parameters of valproic acid to serum protein in healthy adults at steady state.

    abstract::Two hundred milligrams of valproic acid (VPA) was administered orally to seven healthy adults at 9:00 and 21:00 h for 5 consecutive days, including the morning dose on day 6. On the sixth day, blood samples were drawn at 0, 0.17, 0.33, 0.5, 0.75, 1, 1.5, 3, and 6 h after the morning dose. Binding of VPA to serum prote...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199202000-00009

    authors: Kodama Y,Koike Y,Kimoto H,Yasunaga F,Takeyama M,Teraoka I,Fujii I

    更新日期:1992-02-01 00:00:00

  • Determination of itraconazole and its active metabolite in plasma by column liquid chromatography.

    abstract::Itraconazole is a new triazole antifungal agent. Active orally, this drug is effective against a wide range of fungal pathogens that includes Aspergillus species, and its use in leukemic and AIDS patients is currently on the increase. Oral itraconazole absorption presents up to threefold interindividual variation in m...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199412000-00011

    authors: Poirier JM,Lebot M,Descamps P,Levy M,Cheymol G

    更新日期:1994-12-01 00:00:00

  • Monitoring of plasma methadone: intercorrelation between immunoassay and gas chromatography-mass spectrometry.

    abstract::Determination of plasma methadone is essential in connection with dose adjustments for patients participating in methadone maintenance programs. We successfully adapted the existing fluorescence polarization immunoassay (FPIA) kit intended for urinary methadone to plasma assays. A concentration interval of 50-900 ng/m...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:

    authors: Beck O,Boreus LO,Borg S,Jacobsson G,Lafolie P,Stensiö M

    更新日期:1990-09-01 00:00:00

  • Spironolactone as a source of interference in commercial digoxin immunoassays.

    abstract::Eight commercial digoxin immunoassay methods were tested in 17 subjects taking spironolactone (but not digoxin) to evaluate cross-reactivity from parent drug and/or metabolites. Four of these methods showed significant (up to 1.9 nmol/L) and variable "apparent digoxin" concentrations, despite the absence of digoxin in...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198706000-00014

    authors: Morris RG,Lagnado PY,Lehmann DR,Frewin DB,Glistak ML,Burnet RB

    更新日期:1987-06-01 00:00:00

  • Therapeutic drug monitoring of infliximab in spondyloarthritis: an observational open-label study.

    abstract:BACKGROUND:Infliximab is a chimeric monoclonal antibody that binds to human tumor necrosis factor alpha and which is approved for refractory spondyloarthritis (SpA). Individual adjustment of infliximab dosage may help to improve the therapeutic response in SpA. We investigated whether a knowledge of infliximab serum co...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/FTD.0b013e318224f83d

    authors: Méric JC,Mulleman D,Ducourau E,Lauféron F,Miow Lin DC,Watier H,Goupille P,Paintaud G

    更新日期:2011-08-01 00:00:00

  • Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections.

    abstract:BACKGROUND:Colistin is increasingly used as the last therapeutic option for the treatment of multidrug-resistant, Gram-negative bacterial infections. To ensure safe and efficacious use of colistin, therapeutic drug monitoring (TDM) is needed due to its narrow therapeutic window. This study aimed to evaluate the pharmac...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/FTD.0000000000000572

    authors: Kim EJ,Oh J,Lee K,Yu KS,Chung JY,Hwang JH,Nam EY,Kim HS,Kim M,Park JS,Song KH,Kim ES,Song J,Kim HB

    更新日期:2019-02-01 00:00:00

  • Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration.

    abstract::The pharmacokinetics of oxycodone have been determined after single-dose administration by the intravenous (4.6-7.3 mg), oral (tablets, 9.1 mg and syrup, 9.1 mg), and rectal (30 mg) routes, in 48 patients undergoing minor surgery. There were no significant differences in the mean elimination half-lives between the int...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00007691-199212000-00008

    authors: Leow KP,Smith MT,Watt JA,Williams BE,Cramond T

    更新日期:1992-12-01 00:00:00

  • Poor performance of laboratories assaying newly developed antiretroviral agents: results for darunavir, etravirine, and raltegravir from the international quality control program for therapeutic drug monitoring of antiretroviral drugs in human plasma/seru

    abstract:BACKGROUND:The International Interlaboratory Quality Control PROGRAM for Therapeutic Drug Monitoring of Antiretroviral Drugs in Human Plasma/Serum was initiated in 1999. We have previously published our experience during the first 10 years of the PROGRAM. Since 2010, 3 newly developed antiretroviral agents have been ad...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000089

    authors: Burger D,Krens S,Robijns K,Aarnoutse R,Brüggemann R,Touw D

    更新日期:2014-12-01 00:00:00

  • Optimum dosage regimen of palivizumab?

    abstract::Palivizumab is a humanized, monoclonal antibody used to protect at-risk infants against respiratory syncytial virus (RSV) infection. The regular dosage scheme causes a low initial trough level and accumulation of the antibody after subsequent injections. Using a simple pharmacokinetic model, the authors devised an alt...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-200206000-00020

    authors: Zaaijer HL,Vandenbroucke-Grauls CM,Franssen EJ

    更新日期:2002-06-01 00:00:00

  • The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy in mycophenolate mofetil-based renal transplantation.

    abstract::There is increasing evidence that monitoring predose plasma levels of mycophenolic acid (MPA) is of benefit in renal transplant recipients treated with mycophenolate mofetil (MMF). Concomitant treatment with oral antibiotics leads to a 10% to 30% reduction in MPA area under the curve (AUC)0-12, probably by reducing en...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/FTD.0b013e31803111d5

    authors: Borrows R,Chusney G,Loucaidou M,James A,Van Tromp J,Cairns T,Griffith M,Hakim N,McLean A,Palmer A,Papalois V,Taube D

    更新日期:2007-02-01 00:00:00

  • Coloring, bleaching, and perming: influence on EtG content in hair.

    abstract:BACKGROUND:Hair analysis of ethyl glucuronide (EtG) has become, beside fatty acid ethyl ester, a valuable marker for the detection of moderate and chronic excessive alcohol consumption. So far, only few studies exist about the influence of cosmetic treatment on EtG content in hair. The aim of this study was to evaluate...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0b013e31828ca246

    authors: Kerekes I,Yegles M

    更新日期:2013-08-01 00:00:00

  • Oral aripiprazole-induced severe hypoglycemia.

    abstract::This case report highlights a very rare adverse drug reaction caused by oral aripiprazole resulting in severe hypoglycemia. A 72-year-old-male patient suffering from Parkinson disease on prolonged carbidopa plus levodopa combination therapy (carbidopa 25 mg plus levodopa 100 mg, thrice daily) for 1.3 years was recentl...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/FTD.0b013e3182557d10

    authors: Mondal S,Saha I,Das S,Ganguly A,Ghosh A,Kumar Das A

    更新日期:2012-06-01 00:00:00

  • Comparison of a new high-performance liquid chromatography method with fluorescence polarization immunoassay for analysis of methotrexate.

    abstract::A simple high-performance liquid chromatography (HPLC) method for the determination of methotrexate (MTX) in biological fluids is described. The assay is rapid, the time required for analysis is less than 30 min, and it is sensitive, up to 0.01 microgram/ml, which is three times below the toxic MTX concentration. Fift...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199204000-00012

    authors: Najjar TA,Matar KM,Alfawaz IM

    更新日期:1992-04-01 00:00:00

  • Aluminum toxicity in patients with chronic renal failure.

    abstract::During the past two decades, in association with the commencement of chronic dialysis therapy and prolongation of the uremic state, aluminum toxicity has represented a major cause of morbidity and mortality in uremic patients. The uremic patient has been found to be at higher risk of aluminum loading and toxicity from...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/00007691-199312000-00025

    authors: Alfrey AC

    更新日期:1993-12-01 00:00:00

  • High-performance liquid chromatography of clomipramine and metabolites in human plasma and urine.

    abstract::An isocratic, high-performance liquid chromatography method has been developed for simultaneous determination of the tricyclic antidepressant clomipramine and six metabolites: desmethylclomipramine, 2- and 8-hydroxy-clomipramine, 2- and 8-hydroxydesmethylclomipramine and didesmethyl-clomipramine in plasma and urine. I...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199304000-00010

    authors: Nielsen KK,Brøsen K

    更新日期:1993-04-01 00:00:00

  • A simple method to calculate cyclosporine dosage to obtain a target C2 drug level.

    abstract::C(2) Cyclosporine (CsA) level, as a surrogate of area under the time-concentration curve (AUC) 0-4 hours, is a good predictor of drug absorption and clinical outcome after kidney transplantation. It has been difficult to define the optimal C(2) level in the individual case and given the broad range of C(2) due to inte...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-200306000-00022

    authors: Morales J,Buckel E,Fierro A,Zehnder C,Herzog C,Mañalich J

    更新日期:2003-06-01 00:00:00

  • No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children.

    abstract::It has been suggested that lamotrigine (LTG) may enhance the toxicity of carbamazepine (CBZ) by increasing the concentration of the active metabolite carbamazepine-10,11-epoxide (CBZ-E) in adult patients. The authors investigated this hypothesis in an add-on study in 11 children and 3 adolescents, aged 6-22 years, who...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199710000-00002

    authors: Eriksson AS,Boreus LO

    更新日期:1997-10-01 00:00:00

  • Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.

    abstract:BACKGROUND:Ribavirin exposure after the first dose (D0AUC0-4h) >1755 mcg·h·L is predictive of sustained virological response (SVR) in patients with hepatitis C treated with peginterferon and ribavirin. The aim of this study was to test the benefit of ribavirin early dose adjustment based on this target in naïve patient...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1097/FTD.0000000000000332

    authors: Loustaud-Ratti V,Maynard M,Thevenon S,Pradat P,Rousseau A,Alain S,Deny P,Gagnieu MC,Tran A,Dao T,Silvain C,Lunel-Fabiani F,Picard N,Zublena I,Marquet P,Trepo C,RIBAJUSTE Group.

    更新日期:2016-12-01 00:00:00

  • Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug.

    abstract::Drugs metabolized by cytochrome CYP3A isoenzymes have wide interindividual variability and normally distributed plasma clearance distributions. This makes precise dosing difficult to achieve clinically, which may compromise safe therapy. We hypothesized that with potent inhibition of CYP3A, we could clinically render ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/01.ftd.0000194497.55269.d9

    authors: Tham LS,Lee HS,Wang L,Yong WP,Fan L,Ong AB,Sukri N,Soo R,Lee SC,Goh BC

    更新日期:2006-04-01 00:00:00

  • Combined therapy with thioridazine decreases plasma levels of quetiapine inTaiwanese schizophrenic patients.

    abstract:BACKGROUND:In this study, the authors studied the effect of thioridazine (TDZ) on the pharmacokinetic profile of quetiapine (QTP) in Taiwanese patients with schizophrenia. METHODS:Sixteen subjects with schizophrenia were recruited for this study. The authors pretreated 8 patients with TDZ 50 mg daily continuously give...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,多中心研究

    doi:10.1097/FTD.0b013e31825479cc

    authors: Chang SC,Lu ML,Wang YC,Lin FW,Huang SH,Kuo PH,Ho HO,Wu TH

    更新日期:2012-06-01 00:00:00

  • Placental and milk transfer of chloroquine in humans.

    abstract::The placental and milk transfer of chloroquine was studied in seven subjects and six subjects, respectively. Seven pregnant women at term were administered chloroquine phosphate (5 mg/kg) i.m. The maternal blood and arterial and venous umbilical cord blood were obtained during delivery. The maternal chloroquine blood ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198802000-00004

    authors: Akintonwa A,Gbajumo SA,Mabadeje AF

    更新日期:1988-01-01 00:00:00

  • Procainamide-induced myasthenia-like weakness and dysphagia.

    abstract::A 64-year-old man with chronic renal insufficiency was hospitalized with dysphagia and inability to keep his head erect 11 months after beginning procainamide hydrochloride (PA) for control of atrial flutter. Evaluation revealed esophageal dysmotility, worsening renal function, and elevated serum PA and N-acetylprocai...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199306000-00013

    authors: Miller CD,Oleshansky MA,Gibson KF,Cantilena LR

    更新日期:1993-06-01 00:00:00

  • Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events.

    abstract::Tyrosine kinase inhibitors are the standard of care for the treatment of chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib is a second-generation tyrosine kinase inhibitor that has been shown to be efficacious in treatment of patients with chronic myeloid leukemia or ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/FTD.0b013e3181f4d9c5

    authors: Shayani S

    更新日期:2010-12-01 00:00:00

  • Plasma assay of salbutamol by means of high-performance liquid chromatography with amperometric determination using a loop column for injection of plasma extracts. Application to the evaluation of subcutaneous administration of salbutamol.

    abstract::An isocratic high-performance liquid chromatography method with amperometric detection for the assay of plasma salbutamol is described. The plasma extract is injected into the chromatographic system via a loop column. This insures the purification of the injected extracts and allows a simple and rapid liquid-solid ext...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199206000-00011

    authors: Tamisier-Karolak L,Delhotal-Landes B,Jolliet-Riant P,Milliez J,Jannet D,Barre J,Flouvat B

    更新日期:1992-06-01 00:00:00

  • Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.

    abstract::A study was conducted to determine whether assay-specific quantitative differences exist in the determination of vancomycin serum concentrations obtained from patients with renal dysfunction. Vancomycin serum concentrations were obtained during the first week of therapy for each of three time intervals: 48-96 h, 96-14...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/00007691-199612000-00004

    authors: Peckman HJ,Dupuis RE,Sawyer WT,Brouwer KL,Cross RE

    更新日期:1996-12-01 00:00:00

  • Serum Concentrations of Paliperidone After Administration of the Long-Acting Injectable Formulation.

    abstract:BACKGROUND:The pharmacokinetics of long-acting intramuscular paliperidone in a naturalistic setting is not well documented. The objective of this study was to investigate the relationship between dose and serum concentrations of paliperidone using data from a routine therapeutic drug monitoring service. METHODS:Serum ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000457

    authors: Helland A,Spigset O

    更新日期:2017-12-01 00:00:00

  • Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.

    abstract::The ring sulfoxidation of thioridazine (THD), a widely used neuroleptic agent, yields two diastereoisomeric pairs, fast- and slow-eluting (FE and SE) thioridazine 5-sulfoxide (THD 5-SO). Until now, studies in which concentrations of these metabolites were measured in THD-treated patients have revealed no significant d...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:

    authors: Eap CB,Souche A,Koeb L,Baumann P

    更新日期:1991-07-01 00:00:00

  • Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevi

    abstract::Several studies suggest that therapeutic drug monitoring of protease inhibitors and nonnucleoside reverse transcriptase inhibitors may contribute to the clinical outcome of HIV-infected patients. Because of the growing number of antiretroviral drugs and of drug combinations than can be administered to these patients, ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/01.ftd.0000152680.36517.5d

    authors: Poirier JM,Robidou P,Jaillon P

    更新日期:2005-04-01 00:00:00

  • Pharmacodynamic Monitoring of Antiepileptic Drug Therapy.

    abstract::Epilepsy is characterized by seizures recurring at interindividually differing time intervals. It may be difficult to assess drug response if time intervals between seizures are long. Thus, the existence of surrogate parameters that could be used to reliably identify drug efficacy and tolerability at an early stage an...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/FTD.0000000000000623

    authors: Brandt C

    更新日期:2019-04-01 00:00:00